Bone Biologics Executives to be Interviewed in a "CEO Chat" by Zacks Small-Cap Research Analyst on June 20th

Company Overview - Bone Biologics Corporation is focused on developing orthobiologic products for spine fusion markets [1][3] - The company is engaged in regenerative medicine for bone and is working with strategic partners on preclinical research of the Nell-1 protein [3] Upcoming Event - The company's president and CEO, Jeffrey Frelick, and CFO, Deina Walsh, will participate in a "CEO Chat" on June 20, 2024, at the Life Science Investor Forum [1] - The interview will start at 11:00 a.m. Eastern time and will be accessible for investors to view [1][2] - Management will also hold one-on-one meetings with investors on the same day from 11:30 a.m. to 5:00 p.m. Eastern time [1] Investor Engagement - Investors are encouraged to preregister for the event to facilitate participation and receive updates [1] - A chat function will be available for investors to ask questions during the event [1] - The interview will be available for viewing on the company's website for 90 days post-event [2]